Liminatus Pharma (LIMN) traded up 7.48 % during a 24 hours period ending at 10:33 AM Central Europe on Tuesday 27th. One Liminatus Pharma stock can currently be bought for about USD 3.16 on popular exchanges. Current supply of Liminatus Pharma stocks is 1.3 mn. Liminatus Pharma has a current market capitalization of USD 4.1 mn and approximately USD 30.3 k worth of Liminatus Pharma was traded on exchanges in the last 24 hours. Since last month end, Liminatus Pharma has traded -26 % down. Simple moving average of last 200 days is at USD 11.79. The highest price of past 52 weeks was recorded at USD 141.5 on 02/09/2026. 52 weeks low was at USD 2.9 on 10/23/2026.

Here is how related stocks have performed in the past 24 hours:

  • Intelligent Bio (INBS) traded up 3.14 % and now trades at USD 1.64. Current market capitalisation for Intelligent Bio is USD 4.8 mn.

  • Scienture (SCNX) traded up 1.74 % and now trades at USD 2.93. Current market capitalisation for Scienture is USD 4.8 mn.

  • Creative Medical (CELZ) traded down -3.78 % and now trades at USD 0.71. Creative Medical has a market capitalisation of USD 4.9 mn.

  • Longeveron (LGVN) traded up 0.31 % and now trades at USD 1.6. Longeveron has a market capitalisation of USD 4.8 mn.

  • Aim Immunotech (AIM) traded flat 0 % and now trades at USD 0.16. Aim Immunotech has a market capitalisation of USD 4.8 mn.